169 related articles for article (PubMed ID: 16846728)
1. Microencapsulation of Streptococcus equi antigens in biodegradable microspheres and preliminary immunisation studies.
Azevedo AF; Galhardas J; Cunha A; Cruz P; Gonçalves LM; Almeida AJ
Eur J Pharm Biopharm; 2006 Oct; 64(2):131-7. PubMed ID: 16846728
[TBL] [Abstract][Full Text] [Related]
2. Streptococcus equi antigens adsorbed onto surface modified poly-epsilon-caprolactone microspheres induce humoral and cellular specific immune responses.
Florindo HF; Pandit S; Gonçalves LM; Alpar HO; Almeida AJ
Vaccine; 2008 Aug; 26(33):4168-77. PubMed ID: 18599166
[TBL] [Abstract][Full Text] [Related]
3. Antibody and cytokine-associated immune responses to S. equi antigens entrapped in PLA nanospheres.
Florindo HF; Pandit S; Gonçalves LM; Videira M; Alpar O; Almeida AJ
Biomaterials; 2009 Oct; 30(28):5161-9. PubMed ID: 19524290
[TBL] [Abstract][Full Text] [Related]
4. The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles.
Florindo HF; Pandit S; Lacerda L; Gonçalves LM; Alpar HO; Almeida AJ
Biomaterials; 2009 Feb; 30(5):879-91. PubMed ID: 19027152
[TBL] [Abstract][Full Text] [Related]
5. Mucosal or systemic administration of rE2 glycoprotein antigen loaded PLGA microspheres.
Brandhonneur N; Loizel C; Chevanne F; Wakeley P; Jestin A; Le Potier MF; Le Corre P
Int J Pharm; 2009 May; 373(1-2):16-23. PubMed ID: 19429284
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of vaccination with recombinant proteins from Streptococcus equi subspecies equi in a strangles model in the mouse.
Flock M; Karlström A; Lannergård J; Guss B; Flock JI
Vaccine; 2006 May; 24(19):4144-51. PubMed ID: 16580099
[TBL] [Abstract][Full Text] [Related]
7. Mucosal delivery of microparticle encapsulated ESAT-6 induces robust cell-mediated responses in the lung milieu.
Carpenter ZK; Williamson ED; Eyles JE
J Control Release; 2005 May; 104(1):67-77. PubMed ID: 15866335
[TBL] [Abstract][Full Text] [Related]
8. Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems.
Singh J; Pandit S; Bramwell VW; Alpar HO
Methods; 2006 Feb; 38(2):96-105. PubMed ID: 16442811
[TBL] [Abstract][Full Text] [Related]
9. Affects of N-terminal variation in the SeM protein of Streptococcus equi on antibody and fibrinogen binding.
Timoney JF; DeNegri R; Sheoran A; Forster N
Vaccine; 2010 Feb; 28(6):1522-7. PubMed ID: 20005857
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep.
Stanley AC; Buxton D; Innes EA; Huntley JF
Vaccine; 2004 Sep; 22(29-30):3929-41. PubMed ID: 15364441
[TBL] [Abstract][Full Text] [Related]
11. Recombinant hyaluronate associated protein as a protective immunogen against Streptococcus equi and Streptococcus zooepidemicus challenge in mice.
Chanter N; Ward CL; Talbot NC; Flanagan JA; Binns M; Houghton SB; Smith KC; Mumford JA
Microb Pathog; 1999 Sep; 27(3):133-43. PubMed ID: 10455004
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable microspheres alone do not stimulate murine macrophages in vitro, but prolong antigen presentation by macrophages in vitro and stimulate a solid immune response in mice.
Luzardo-Alvarez A; Blarer N; Peter K; Romero JF; Reymond C; Corradin G; Gander B
J Control Release; 2005 Dec; 109(1-3):62-76. PubMed ID: 16269200
[TBL] [Abstract][Full Text] [Related]
13. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
14. In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation.
Peyre M; Fleck R; Hockley D; Gander B; Sesardic D
Vaccine; 2004 Jun; 22(19):2430-7. PubMed ID: 15193406
[TBL] [Abstract][Full Text] [Related]
15. Protective immunity in rats by intranasal immunization with Streptococcus mutans glucan-binding protein D encapsulated into chitosan-coated poly(lactic-co-glycolic acid) microspheres.
Zhao H; Wu B; Wu H; Su L; Pang J; Yang T; Liu Y
Biotechnol Lett; 2006 Aug; 28(16):1299-304. PubMed ID: 16804764
[TBL] [Abstract][Full Text] [Related]
16. Vaccination of horses against strangles using recombinant antigens from Streptococcus equi.
Waller A; Flock M; Smith K; Robinson C; Mitchell Z; Karlström A; Lannergård J; Bergman R; Guss B; Flock JI
Vaccine; 2007 May; 25(18):3629-35. PubMed ID: 17321016
[TBL] [Abstract][Full Text] [Related]
17. Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis.
Lima KM; Santos SA; Lima VM; Coelho-Castelo AA; Rodrigues JM; Silva CL
Gene Ther; 2003 Apr; 10(8):678-85. PubMed ID: 12692596
[TBL] [Abstract][Full Text] [Related]
18. Intranasal vaccination with SfbI or M protein-derived peptides conjugated to diphtheria toxoid confers protective immunity against a lethal challenge with Streptococcus pyogenes.
Schulze K; Olive C; Ebensen T; Guzmán CA
Vaccine; 2006 Aug; 24(35-36):6088-95. PubMed ID: 16828529
[TBL] [Abstract][Full Text] [Related]
19. New approach on the development of a mucosal vaccine against strangles: Systemic and mucosal immune responses in a mouse model.
Florindo HF; Pandit S; Gonçalves LM; Alpar HO; Almeida AJ
Vaccine; 2009 Feb; 27(8):1230-41. PubMed ID: 19114079
[TBL] [Abstract][Full Text] [Related]
20. Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine.
Elvin SJ; Eyles JE; Howard KA; Ravichandran E; Somavarappu S; Alpar HO; Williamson ED
Vaccine; 2006 May; 24(20):4433-9. PubMed ID: 16546306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
